SCHEMBL29955071

SCHEMBL29955071

COc1cc(C#N)ccc1C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
TSHR P16473 2/20 0.50
KDM4E B2RXH2 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.49
AR P10275 3/20 0.47
NPC1 O15118 1/20 0.44
POLB P06746 1/20 0.44
RAB9A P51151 1/20 0.44
PRKDC P78527 1/20 0.42
LMNA P02545 1/20 0.41
HPGD P15428 1/20 0.41
GAK O14976 1/20 0.40
RIPK2 O43353 1/20 0.40
COQ8A Q8NI60 1/20 0.40
NLK Q9UBE8 1/20 0.40
ERN1 O75460 2/20 0.40
TRIM24 O15164 1/20 0.40
TYR P14679 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1398327 1.00 ALDH1A1 (0.58) ALDH1A1TSHRKDM4ETDP1L3MBTL1
SCHEMBL29950818 0.86 ALDH1A1 (0.50) ALDH1A1TSHRKDM4ETDP1AR
SCHEMBL5221782 0.86 ALDH1A1 (0.50) ALDH1A1TSHRKDM4ETDP1AR
SCHEMBL2637060 0.84 APP (0.51) ALDH1A1TSHRKDM4ETDP1L3MBTL1
SCHEMBL2637062 0.84 APP (0.51) ALDH1A1TSHRKDM4ETDP1L3MBTL1
SCHEMBL27921460 0.82 ALDH1A1 (0.58) ALDH1A1TSHRKDM4ETDP1L3MBTL1
SCHEMBL21162204 0.82 AR (0.47) ALDH1A1ARGAKRIPK2COQ8A
SCHEMBL18570516 0.82 AR (0.54) ALDH1A1ARERN1
SCHEMBL3699034 0.81 ALDH1A1 (0.52) ALDH1A1ARLMNAHPGDCYP1A2
SCHEMBL11980116 0.78 TRPV4 (0.39) ALDH1A1L3MBTL1ARHPGDRAD51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026107227-A1 COMPOSITIONS COMPRISING USP1 INHIBITORS AND METHODS OF USING THE SAME EIKON THERAPEUTICS, INC. (US) 2026-05-21 WO disclosed
EP-4526302-A1 PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF Alivus Life Sciences Limited (IN) 2025-03-26 EP disclosed
EP-4511365-A1 PROCESSES FOR THE PREPARATION OF FINERENONE Teva Pharmaceuticals International GmbH (CH) 2025-02-26 EP disclosed
CN-119219624-A Dihydronaphthalene amide preparation method of class compound 江苏吴中医药集团有限公司 2024-12-31 CN disclosed
WO-2024075139-A1 A PROCESS FOR PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF MAITHRI DRUGS PRIVATE LIMITED (IN) 2024-04-11 WO disclosed
EP-4286368-A1 METHOD FOR THE PREPARATION OF 4-FORMYL-3-METHOXYBENZONITRILE Bayer Aktiengesellschaft (DE) 2023-12-06 EP disclosed
WO-2023223188-A1 PROCESS FOR THE PREPARATION OF FINERENONE AND INTERMEDIATES THEREOF GLENMARK LIFE SCIENCES LIMITED (IN) 2023-11-23 WO disclosed
WO-2023205164-A1 PROCESSES FOR THE PREPARATION OF FINERENONE TEVA PHARMACEUTICALS INTERNATIONAL GMBH (CH) 2023-10-26 WO disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed